Hospitalizaciones asociadas a VRS en menores de 24 meses

Early Life RSV: Can Vaccines Help Fix Societal Ills?

Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis

Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children

VRS -Associated Outpatient Visits Among Children Younger Than 24 Months

Viral Loads and Disease Severity in Young Children With VRS

Common Human Coronavirus Clinical Impact of Codetected Respiratory Syncytial Virus

VRS-attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia

Intravenous palivizumab in respiratory syncytial virus infection

Unexpected peak of bronchiolitis requiring oxygen therapy in February 2020

Risk of childhood wheeze and asthma after respiratory syncytial virus infection

Impact of Social Distancing in Response to Coronavirus on Hospitalizations for VRS

VRS activity 2021

Innate Immune Dysfunction and Severe Respiratory Syncytial Virus Bronchiolitis

Whole blood gene expression to assess pathogenesis in infants with VRS

Shifting the paradigm: host gene signatures for diagnosis of infectious diseases

Immune profiles provide insights into VRS disease severity in children

The journey to a respiratory syncytial virus vaccine